Carbopa – Carboplatin Injection
Carboplatin (Carbopa) Injection – Treatment for Ovarian Cancer and Small Cell Lung Cancer
Carbopa 150mg/450mg Injections are used to treat both ovarian cancer and small cell lung cancer. Carbopa injection is available in two strengths: 150mg and 450mg. Its effectiveness is demonstrated by the fact that it stops or slows the proliferation of cancer cells.
Carbopa Under the direction of a doctor, injection is delivered as an injection into veins. Your doctor will determine the appropriate dose and frequency of administration. This can vary depending on the reason you’re being treated and may alter over time. You should follow your doctor’s instructions in the letter. It can have potentially dangerous negative effects if taken incorrectly or in excess. You may not see or feel the advantages for several weeks or months, but do not stop taking it until your doctor advises you to.
USES OF CARBOPLATIN (CARBOPA) 150MG/450MG INJECTION
- Ovarian cancer
- Small cell lung cancer
WORKS OF CARBOPLATIN (CARBOPA) 150MG/450MG INJECTION
Carbopa Injection is a cancer-fighting drug. It acts by destroying the cancer cells’ genetic material (DNA and RNA), halting their development and proliferation.
SIDE EFFECTS OF CARBOPLATIN (CARBOPA) 150MG/450MG INJECTION
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Peripheral neuropathy
WARNING & PRECAUTIONS
Carbopa Injections can make you drowsy and dizzy by lowering your alertness, affecting your eyesight, or making you sleepy and dizzy. If you have any of these symptoms, you should not drive.
In individuals with renal illness, Carbopa Injection should be used with care. Carbopa Injection dosage may need to be adjusted. Please seek medical advice.
In individuals with severe renal disease, Carbopa Injection is not indicated. While using this medication, you should get your kidney function tested on a regular basis.
In people with liver problems, carbopa Injection is probably safe to use. Based on the limited information provided, a dosage change of Carbopa Injection may not be necessary in these individuals. Please seek medical advice.
Carbopa Injections should not be used during pregnancy since there is clear evidence that they pose a risk to the growing fetus. However, in some life-threatening instances where the advantages outweigh the hazards, the doctor may prescribe it. Please seek medical advice.
Carbopa injections used during nursing is risky. The medicine may induce toxicity in the newborn, according to the data.
Fedelty Health Care is a Carboplatin third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.